{"id":47142,"title":"Discontinuation of mass  azithromycin distribution for trachoma: a systematic review","title_html":"<p>Discontinuation of mass  azithromycin distribution for trachoma: a systematic review<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bsaenabe","doi_status":2,"uri":"discontinuation-of-mass-azithromycin-distribution-bsaenabe","type_id":1,"template_id":1,"published_on":1625846762,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"bsaenabe","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1612949520,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"Hamidah Mahmud","affiliation":null,"affiliations":[],"username":"m4vle112u105xle1","note":null,"link":"https:\/\/doi.org\/10.1371\/journal.pntd.0009491","image":{"source":"\/img\/avatars\/016.png","placeholder":"\/img\/avatars\/016.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"has_versions":0,"link":"https:\/\/doi.org\/10.1371\/journal.pntd.0009491","total_collections":0,"number_of_steps":15,"authors":[{"name":"hamidah.mahmud ","affiliation":"Francis I. Proctor Foundation, University of California, San Francisco, California, USA","affiliations":[],"username":"m4vle112u105yle1","note":"","link":null,"image":{"source":"\/img\/avatars\/016.png","placeholder":"\/img\/avatars\/016.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Catherine Oldenburg","affiliation":"Francis I. Proctor Foundation, University of California, San Francisco, California, USA","affiliations":[],"username":"w2z28403p2x2","note":"","link":null,"image":{"source":"\/img\/avatars\/003.png","placeholder":"\/img\/avatars\/003.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/discontinuation-of-mass-azithromycin-distribution-bsaenabe","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"100B16006B8011EBA9DDBB393231DAE5","state_version_id":1923,"steps":[{"id":1123233,"guid":"E13995606B8211EBA9DDBB393231DAE5","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"0FC9F5E92D034AB7BAB7A30A4E7CC15B","order_id":1,"type_id":6,"title":"Section","source":{"title":"Review questions "}},{"id":1054724,"guid":"C1A559D553704EAC8CCA4DA37F14EB2D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">1.\u00a0What is the prevalence of clinical trachoma (TF) and ocular chlamydia infection pre-MDA and post MDA?<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123234,"guid":"E13A7FC06B8211EBA9DDBB393231DAE5","previous_id":1123233,"previous_guid":"E13995606B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"9F1A59206B8D448DB07C9C2F42922DA8","order_id":1,"type_id":6,"title":"Section","source":{"title":"Review questions "}},{"id":1054724,"guid":"22147A3920514ED0B02B82BDDE0A3864","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">2.\u00a0Is there a correlation between pre-treatment trachoma prevalence and return of trachoma infection prevalence after discontinuing oral azithromycin treatment?<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123236,"guid":"E13C7B916B8211EBA9DDBB393231DAE5","previous_id":1123234,"previous_guid":"E13A7FC06B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"ADDEA6799B8A490DB6EE4B05810BCD1B","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search strategy "}},{"id":1054724,"guid":"595625060411429D919123DF2A4DFF74","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Search Items: <\/div><div class = \"text-block\">-Trachoma<\/div><div class = \"text-block\">-Azithromycin<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123239,"guid":"E13FFE016B8211EBA9DDBB393231DAE5","previous_id":1123236,"previous_guid":"E13C7B916B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"0D4A9BF5A948425D80121437C2182332","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search strategy "}},{"id":1054724,"guid":"6D770BBA5DD1426BB7BF1369A24594A4","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Synonyms to be searched, if needed:<\/div><div class = \"text-block\">- Azithromycin: Zithromax\u00a0<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123241,"guid":"E14332516B8211EBA9DDBB393231DAE5","previous_id":1123239,"previous_guid":"E13FFE016B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"570AC781E7774C51BF7CEDBCEF5CFE52","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search strategy "}},{"id":1054724,"guid":"9023CA128E154D98B9523507785C150E","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Search algorithm:<\/div><div class = \"text-block\">(\"Trachoma\"[Mesh] OR trachoma) AND (\"Azithromycin\"[Mesh] OR azithromycin OR zithromax)\u00b7<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123243,"guid":"E147C6306B8211EBA9DDBB393231DAE5","previous_id":1123241,"previous_guid":"E14332516B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"90AB719BA8054A2490F6E270447FF609","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search strategy "}},{"id":1054724,"guid":"A395C4B928A64B2BBB1B0D0CB7FAB240","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Databases searched and search details:<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0MEDLINE<\/div><div class = \"text-block\">Search bar:<\/div><div class = \"text-block\">(\"Trachoma\"[Mesh] OR trachoma) AND (\"Azithromycin\"[Mesh] OR azithromycin OR zithromax)<\/div><div class = \"text-block\">Full search details:<\/div><div class = \"text-block\">(\"Trachoma\"[Mesh] OR (\"trachoma\"[MeSH Terms] OR \"trachoma\"[All Fields])) AND (\"Azithromycin\"[Mesh] OR (\"azithromycin\"[MeSH Terms] OR \"azithromycin\"[All Fields]) OR (\"azithromycin\"[MeSH Terms] OR \"azithromycin\"[All Fields] OR \"zithromax\"[All Fields]))<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0EMBASE<\/div><div class = \"text-block\">Search bar:<\/div><div class = \"text-block\">('trachoma'\/exp OR trachoma) AND ('azithromycin'\/exp OR azithromycin)<\/div><div class = \"text-block\">o\u00a0\u00a0 Web of Science<\/div><div class = \"text-block\">Search bar (TOPIC):<\/div><div class = \"text-block\">(\"Trachoma\"[Mesh] OR trachoma) AND (\"Azithromycin\"[Mesh] OR azithromycin OR zithromax)<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Cochrane Library<\/div><div class = \"text-block\">Search bar (Title, Abstract, Keywords):<\/div><div class = \"text-block\">Trachoma AND azithromycin<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123258,"guid":"E16587616B8211EBA9DDBB393231DAE5","previous_id":1123243,"previous_guid":"E147C6306B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"EA7AE832CFD04A4188A3D8B485E8AE2A","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search strategy "}},{"id":1054724,"guid":"861A02D7415940968B8A9CB1A16EEA5A","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Other sources:<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Abstracts<\/div><div class = \"text-block\">Abstracts available online from the following conferences will be searched using the search terms outlined above:<\/div><div class = \"text-block\">\u00b7\u00a0American Society of Tropical Medicine and Hygiene (ASTMH)<\/div><div class = \"text-block\">\u00b7\u00a0Association for Research in Vision and Ophthalmology (ARVO)<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123263,"guid":"E1731BF06B8211EBA9DDBB393231DAE5","previous_id":1123258,"previous_guid":"E16587616B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"583B3EAB75294534AE78AC5A62F4887F","order_id":1,"type_id":6,"title":"Section","source":{"title":"Article eligibility criteria"}},{"id":1054724,"guid":"83E9C4A4B28840F785F6E97084925D32","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Inclusion criteria:<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Primary, quantitative data<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Studies of community-wide oral azithromycin distribution for trachoma<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Includes measurement of prevalence of ocular chlamydia and\/or clinical trachoma before and after azithromycin distribution<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Studies must include one pre-treatment time point and at least two post-treatment time points<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Dates of inclusion:\u00a0All primary abstracts, reports, etc. published through May 2020<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#84CE84","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123270,"guid":"E18CBE706B8211EBA9DDBB393231DAE5","previous_id":1123263,"previous_guid":"E1731BF06B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"F557F0F32DA843F5A71AFFEFA833DE0A","order_id":1,"type_id":6,"title":"Section","source":{"title":"Article eligibility criteria"}},{"id":1054724,"guid":"A35A53A9CC5140AE82D5167DB33B326B","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Exclusion criteria:<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Studies on mathematical modeling, surveillance reports, review articles<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Studies without sufficient information on number of individuals\/ villages tested<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Studies without two distinct time points of pre- and post- azithromycin distribution<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Studies on the use of azithromycin for purposes other than treatment of trachoma<\/div><div class = \"text-block\">We will not exclude studies that concurrently use topical tetracycline for trachoma treatment<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#84CE84","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123277,"guid":"E1A4B3406B8211EBA9DDBB393231DAE5","previous_id":1123270,"previous_guid":"E18CBE706B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"DB956F3BD5004481B0BBE42873B26491","order_id":1,"type_id":6,"title":"Section","source":{"title":"Outcomes"}},{"id":1054724,"guid":"1140C82C45E44198906E7F100019CE3D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Primary outcomes of interest:<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Prevalence of clinical trachoma pre-MDA and post-MDA<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Prevalence of ocular chlamydia infection pre-MDA and post-MDA<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123280,"guid":"E1AF61A16B8211EBA9DDBB393231DAE5","previous_id":1123277,"previous_guid":"E1A4B3406B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"F4D77A4378D0491FA5CC9ABF7B736648","order_id":1,"type_id":6,"title":"Section","source":{"title":"Outcomes"}},{"id":1054724,"guid":"6ED58AEC7B1C42B2907AE5B520EEBA7D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Secondary outcomes<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Correlation between pre- and post-MDA prevalence of clinical trachoma if possible<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Correlation between pre- and post-MDA prevalence of ocular chlamydia infection if possible<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123284,"guid":"E1BF19106B8211EBA9DDBB393231DAE5","previous_id":1123280,"previous_guid":"E1AF61A16B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"BAD762F84C634480B194101D9A4342BB","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Extraction"}},{"id":1054724,"guid":"B16470FD4570493198CC4CBEBC4BE96D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Variables to extract:<\/div><div class = \"text-block\">o\u00a0\u00a0 Title<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Authors<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Journal<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Year of publication<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Study design<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Geographic location of study<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Sample size (numbers of communities, numbers of individuals)<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Pre-MDA trachoma prevalence (ocular chlamydia infection and\/or clinical trachoma\/TF)<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Post-MDA trachoma prevalence (ocular chlamydia infection and\/or clinical trachoma\/TF)<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Frequency of MDA<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Duration of MDA\u00a0\u00a0<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#EA9F6C","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123292,"guid":"E1EF77E06B8211EBA9DDBB393231DAE5","previous_id":1123284,"previous_guid":"E1BF19106B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"59F93379196F4648B4D09D527AEC986B","order_id":1,"type_id":6,"title":"Section","source":{"title":"Analysis"}},{"id":1054724,"guid":"04BEA5B3AB0243809CF29C0C29514454","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Strategy for data synthesis (qualitative, quantitative):<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0A qualitative synthesis of individual studies will be performed to discuss individual findings per the variables extracted.<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0For quantitative synthesis, a meta-analysis will be performed per the procedures outlined below<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#E57785","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123295,"guid":"E2045F706B8211EBA9DDBB393231DAE5","previous_id":1123292,"previous_guid":"E1EF77E06B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"DD360497588C4207BD405C996F2D695C","order_id":1,"type_id":6,"title":"Section","source":{"title":"Analysis"}},{"id":1054724,"guid":"7F2CAED9ED5742D1A10328413699C7F3","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">\u00a0Meta-analysis (if data is not too heterogenic to allow):<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Estimates of prevalence pre- and post-MDA will be pooled across studies using a DerSimonian and Laird random effects model for overall prevalence of each outcome (clinical trachoma and ocular chlamydia infection)<\/div><div class = \"text-block\">-Pre-MDA prevalence is predicting post-MDA prevalence<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0The I\u00b2\u00a0statistic will be calculated as a measure of heterogeneity across studies. Sources of heterogeneity, including pre-MDA trachoma prevalence, country of origin, and year, will be evaluated using a random effects meta-regression model.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#E57785","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1123299,"guid":"E2241C706B8211EBA9DDBB393231DAE5","previous_id":1123295,"previous_guid":"E2045F706B8211EBA9DDBB393231DAE5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"483FE8C9F9E347C6A5BF661BB7BACC50","order_id":1,"type_id":6,"title":"Section","source":{"title":"Analysis"}},{"id":1054724,"guid":"81116C6F083D4934B0E4AB099AAE456F","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Quality Assessment<\/div><div class = \"text-block\">o\u00a0\u00a0\u00a0Risk of bias will be assessed using the Cochrane risk of bias tool for randomized controlled trials and the ROBINS-I tool for non-randomized studies<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#E57785","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":"","materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>The WHO recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years. Azithromycin targets the ocular strains of<\/span><span style = \"font-style:italic;\">Chlamydia trachomatis<\/span><span>that cause trachoma. Regions with low prevalence of active trachoma may have little if any ocular chlamydia, and thus may not benefit from azithromycin treatment. Understanding what happens to active trachoma and ocular chlamydia prevalence after mass distributions of azithromycin are discontinued may improve future treatment decisions. We systematically reviewed published evidence for community prevalence of both active trachoma and ocular chlamydia after cessation of azithromycin distribution. We included published studies from the peer-reviewed literature that included at least two post-discontinuation of mass azithromycin distribution surveys of ocular chlamydia and\/or trachomatous inflammation\u2014follicular (TF) prevalence. We assessed trends in the prevalence of both indicators over time after azithromycin discontinuation. We searched electronic databases for publications up through May 20, 2020. Of 140 identified studies, 21 met inclusion criteria and were used for qualitative synthesis. Although we found a gradual increase in ocular chlamydia infection prevalence over time post-discontinuation of azithromycin distribution, the TF prevalence generally gradually declined. Ocular chlamydia infection may return faster in communities compared to TF following discontinuation of treatment.<\/span><\/div><\/div>","changed_on":1625846762}